Showing results (491-500 of 2,823) with videos related to

Sort By:
Pageof 283
Cytotherapy|February 28, 2026
Umbilical cord blood-derived natural killer cells as a viable and potent source for adoptive cell therapyRaquel de Melo Alves-Paiva, Larissa L Coa, Julia T Azevedo, et al.
Cytotherapy|December 27, 2016
Biodegradable poly-ε-caprolactone microcarriers for efficient production of human mesenchymal stromal cells and secreted cytokines in batch and fed-batch bioreactorsAlan Tin-Lun Lam, Jian Li, Jessica Pei-Wen Toh, et al.
Cytotherapy|December 27, 2016
A consensus introduction to serum replacements and serum-free media for cellular therapiesOhad Karnieli, Oryan Makler Friedner, Julie G Allickson, et al.
Cytotherapy|December 29, 2016
Impact of local injection of brain-derived neurotrophic factor-expressing mesenchymal stromal cells (MSCs) combined with intravenous MSC delivery in a canine model of chronic spinal cord injurySeung Hoon Lee, Yongsun Kim, Daeun Rhew, et al.
Cytotherapy|March 20, 2014
Soluble factors derived from human amniotic epithelial cells suppress collagen production in human hepatic stellate cellsAlexander Hodge, Dinushka Lourensz, Vijesh Vaghjiani, et al.
Cytotherapy|April 15, 2014
Age influence on stromal vascular fraction cell yield obtained from human lipoaspiratesSeveriano Dos-Anjos Vilaboa, María Navarro-Palou, Ramón Llull
Cytotherapy|April 15, 2014
Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion SystemPatrick J Hanley, Zhuyong Mei, April G Durett, et al.
Cytotherapy|April 10, 2014
Crohn's disease complicated by hepatitis B virus successfully treated with the use of adsorptive depletion of myeloid lineage leucocytes to suppress inflammatory cytokine profileYoko Yokoyama, Ken Fukunaga, Koji Kamikozuru, et al.
Cytotherapy|April 18, 2008
Immunophenotype characterization of rat mesenchymal stromal cellsMt Harting, F Jimenez, S Pati, et al.
Cytotherapy|April 18, 2008
Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant diseaseAc Hobeika, T Osada, D Serra, et al.
Pageof 283